Product References
ATP13A1 prevents ERAD of folding-competent mislocalized and misoriented proteins.
Molecular cell
McKenna MJ,Adams BM,Chu V,Paulo JA,Shao S
Thu Nov 17 00:00:00 UTC 2022
Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy.
Neuron
Harbauer AB,Hees JT,Wanderoy S,Segura I,Gibbs W,Cheng Y,Ordonez M,Cai Z,Cartoni R,Ashrafi G,Wang C,Perocchi F,He Z,Schwarz TL
Wed May 04 00:00:00 UTC 2022
Serine palmitoyltransferase assembles at ER-mitochondria contact sites.
Life science alliance
Aaltonen MJ,Alecu I,König T,Bennett SA,Shoubridge EA
Tue Feb 01 00:00:00 UTC 2022
MTCH2 is a mitochondrial outer membrane protein insertase.
Science (New York, N.Y.)
Guna A,Stevens TA,Inglis AJ,Replogle JM,Esantsi TK,Muthukumar G,Shaffer KCL,Wang ML,Pogson AN,Jones JJ,Lomenick B,Chou TF,Weissman JS,Voorhees RM
Fri Oct 21 00:00:00 UTC 2022
Mitochondrial antiviral-signalling protein is a client of the BAG6 protein quality control complex.
Journal of cell science
Roboti P,Lawless C,High S
Sun May 01 00:00:00 UTC 2022
The endoplasmic reticulum P5A-ATPase is a transmembrane helix dislocase.
Science (New York, N.Y.)
McKenna MJ,Sim SI,Ordureau A,Wei L,Harper JW,Shao S,Park E
Fri Sep 25 00:00:00 UTC 2020
Sam50 Regulates PINK1-Parkin-Mediated Mitophagy by Controlling PINK1 Stability and Mitochondrial Morphology.
Cell reports
Jian F,Chen D,Chen L,Yan C,Lu B,Zhu Y,Chen S,Shi A,Chan DC,Song Z
Tue Jun 05 00:00:00 UTC 2018
Sam50 Regulates PINK1-Parkin-Mediated Mitophagy by Controlling PINK1 Stability and Mitochondrial Morphology.
Cell reports
Jian F,Chen D,Chen L,Yan C,Lu B,Zhu Y,Chen S,Shi A,Chan DC,Song Z
Tue Jun 05 00:00:00 UTC 2018
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.
Oncotarget
Wang M,Wu H,Li S,Xu Z,Li X,Yang Y,Li B,Li Y,Guo J,Chen H
Fri Oct 27 00:00:00 UTC 2017
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.
Oncotarget
Wang M,Wu H,Li S,Xu Z,Li X,Yang Y,Li B,Li Y,Guo J,Chen H
Fri Oct 27 00:00:00 UTC 2017
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.
Oncotarget
Wang M,Wu H,Li S,Xu Z,Li X,Yang Y,Li B,Li Y,Guo J,Chen H
Fri Oct 27 00:00:00 UTC 2017
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.
Oncotarget
Wang M,Wu H,Li S,Xu Z,Li X,Yang Y,Li B,Li Y,Guo J,Chen H
Fri Oct 27 00:00:00 UTC 2017
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.
Oncotarget
Wang M,Wu H,Li S,Xu Z,Li X,Yang Y,Li B,Li Y,Guo J,Chen H
Fri Oct 27 00:00:00 UTC 2017
SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling.
Oncotarget
Wang M,Wu H,Li S,Xu Z,Li X,Yang Y,Li B,Li Y,Guo J,Chen H
Fri Oct 27 00:00:00 UTC 2017
SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR
Liu X,Zhou J,Zhou N,Zhu J,Feng Y,Miao X
Wed Jul 20 00:00:00 UTC 2016
SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR
Liu X,Zhou J,Zhou N,Zhu J,Feng Y,Miao X
Wed Jul 20 00:00:00 UTC 2016
SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR
Liu X,Zhou J,Zhou N,Zhu J,Feng Y,Miao X
Wed Jul 20 00:00:00 UTC 2016
SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.
Journal of experimental & clinical cancer research : CR
Liu X,Zhou J,Zhou N,Zhu J,Feng Y,Miao X
Wed Jul 20 00:00:00 UTC 2016